Placebo-controlled trial of pharmacokinetics, pharmacodynamics and tolerability of KL130008 capsule in patients with rheumatoid arthritis

This is a Human Clinical Trial study.

Key Points

KL130008 demonstrates promising pharmacokinetics and tolerability in treating rheumatoid arthritis, indicating favorable outcomes.
The trial involved a placebo-controlled design to accurately assess the effectiveness of the KL130008 capsule.
Observational analysis included various pharmacodynamic metrics to determine treatment impact on rheumatoid arthritis symptoms.
Further studies are needed to confirm the efficacy of KL130008 in broader populations with rheumatoid arthritis.

We only have this paper's title and publication details.

Placebo-controlled trial examines tolerability and pharmacokinetics of KL130008 in rheumatoid arthritis, suggesting potential benefits for treatment.

Registered in the Chinese Clinical Trial Register (ChiCTR2000029360).

No takes yet. Share an insight, caveat, or question.

Cheng et al. (2025) studied this question.

View at Publisher

Ask AI

Bookmark

Share